Erratum: Expression of thyrotropin and thyroid hormone receptors in the adipose tissue of patients with morbid obesity and/or type 2 diabetes: Effects of weight loss (International Journal of Obesity (2009) 33 (1001-1006) DOI: 10.1038/ijo.2009.140));Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: Effects of weight loss

International Journal of Obesity

Volumn 33, Issue 9, 2009, Pages 1001-1006

  Nannipieri, M ^a,b   Cecchetti, F ^a   Anselmino, M ^c   Camastra, S ^a   Niccolini, P ^b   Lamacchia, M ^c   Rossi, M ^c   Iervasi, G ^b   Ferrannini, E ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Body weight; Thyroid hormone receptor; TSH receptor

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METFORMIN; RNA; SULFONYLUREA DERIVATIVE; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR ALPHA 1; THYROTROPIN; UNCLASSIFIED DRUG; THYROID HORMONE RECEPTOR; THYROTROPIN RECEPTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RNA EXTRACTION; STOMACH BYPASS; SUBCUTANEOUS FAT; THERAPY EFFECT; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; WEIGHT REDUCTION; BLOOD; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OBESITY, MORBID; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GENE EXPRESSION REGULATION; HUMANS; INTRA-ABDOMINAL FAT; MALE; OBESITY, MORBID; PROSPECTIVE STUDIES; RECEPTORS, THYROID HORMONE; RECEPTORS, THYROTROPIN; SUBCUTANEOUS FAT; THYROTROPIN; WEIGHT LOSS;

EID: 70349109183     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.246     Document Type: Erratum

References (29)

1. Davies TF, Andi T, Lin RY, Tomer Y, Latif R. Thyrotropin receptor-associated diseases: from adenoma to Graves disease. J Clin Invest 2005; 115: 1972-1983.
2. Davies TF, Marians R, Latif R. The TSH receptor reveals itself. J Clin Invest 2002; 110: 161-164.
3. Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, Ovesen L et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005; 90: 4019-4024.
4. Nyrnes A, Jorde R, Sundsfjord J. Serum TSH is positively associated with BMI. Int J Obes 2006; 30: 100-105.
5. Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG et al. Thyroid function in humans with morbid obesity. Thyroid 2006; 16: 73-78.
6. De Pergola D, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol 2007; 67: 265-269.
7. Manji N, Boelaert K, Sheppard MC, Holder RL, Gough SC, Franklyn JA. Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clin Endocrinol 2006; 64 : 125-128.
8. Kok P, Roelfsema F, Langendonk JG, Frölich M, Burggraaf J, Meinders AE et al. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab 2005; 90: 4659-4663.
9. Chikunguwo S, Brethauer S, Nirujogi V, Pitt T, Udomsawaengsup S, Chand B et al. Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis 2007; 3: 631-635.
10. Camastra S, Manco M, Frascerra S, Iaconelli A, Mingrone G, Ferrannini E. Daylong pituitary hormones in morbid obesity: effects of bariatric surgery. Int J Obes 2009; 33: 166-172.
11. Sorisky A, Bell A, Gagnon A. TSH receptor in adipose cells. Horm Metab Res 2000; 32: 468-474.
12. Bell A, Gagnon A, Grunder L, Parikh SJ, Smith TJ, Sorisky A. Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol Cell Physiol 2000; 279: C335-C340.
13. Schaffler A, Binart N, Schölmerich J, Büchler C. Hypothesis paper brain talks with fat-evidence for a hypothalamic-pituitary-adipose axis? Neuropeptides 2005; 39: 363-367.
14. Valyasevi RW, Harteneck DA, Dutton CM, Bahn RS. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 2002; 87: 2352-2358.
15. Janson A, Karlsson FA, Micha-Johansson G, Bolme P, Brönnegård M, Marcus C. Effects of stimulatory and inhibitory thyrotropin receptor antibodies on lipolysis in infant adipocytes. J Clin Endocrinol Metab 1995; 80: 1712-1716.
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002; 25: S5-S20.
17. Nannipieri M, Manganiello M, Pezzatini A, De Bellis A, Seghieri G, Ferrannini E. Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension. Hypertension 2001; 37: 1416-1422.
18. Grohmann M, Sabin M, Holly J, Shield J, Crowne E, Stewart C. Characterization of differentiated subcutaneous and visceral adipose tissue from children: the influences of TNF-alpha and IGF-1. J Lipid Res 2005; 46: 93-103.
19. Krotkiewski M. Thyroid hormones in pathogenesis and treatment of obesity. Eur J Pharmacol 2002; 440: 85-98.
20. Reinehr T, Andler W. Thyroid hormones before and after weight loss in obesity. Arch Dis Child 2002; 87: 320-323.
21. Shimura H, Miyazaki A, Haraguchi K, Endo T, Onaya T. Analysis of differentiation-induced expression mechanisms of thyrotropin receptor gene in adipocytes. Mol Endocrinol 1998; 12: 1473-1486.
22. Endo T, Ohno M, Kotani S, Gunji K, Onaya T. Thyrotropin receptor in non-thyroid tissues. Biochem Biophys Res Commun 1993; 190: 774-779.
23. Antunes TT, Gagnon A, Chen B, Pacini F, Smith TJ, Sorisky A. Interleukin-6 release from human abdominal adipose cells is regulated by thyroid-stimulating hormone: effect of adipocyte differentiation and anatomic depot. Am J Physiol Endocrinol Metab 2006; 209: E1140-E1144.
24. Mendez C, Baldelli R, Camina JP, Escudero B, Peino R, Dieguez C et al. TSH stimulates leptin secretion by a direct effect on adipocytes. J Endocrinol 2003; 176: 7-12.
25. Marcus C, Ehren H, Bolme P, Arner P. Regulation of lipolysis during neonatal period. Importance of thyrotropin. J Clin Invest 1988; 82: 1793-1797.
26. Haraguchi K, Shimura H, Kawaguchi A, Ikeda M, Endo T, Onaya T. Effects of thyrotropin on the proliferation and differentiation of cultured rat preadipocytes. Thyroid 1999; 9: 613-619.
27. Nannipieri M, Bonotti A, Anselmino M, Cecchetti F, Mancini E, Baldi S et al. Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state. Int J Obes 2007; 31: 1843-1848.
28. Foley JE, Laursen AL, Sonne O, Gliemann J. Insulin binding and hexose transport in rat adipocytes. Relation to cell size. Diabetologia 1980; 19: 234-241.
29. Mouradian M, Abourizk N. Diabetes mellitus and thyroid disease. Diabetes Care 1983; 6: 512-520.